YAP (Yes-associated protein) regulates cell growth, tissue homeostasis, and organ size as a transcription co-activator in the Hippo tumor suppressor pathway. The kinase Lats inhibits YAP by phosphorylating it, causing it to localize to the cytoplasm and be degraded by proteasomes. By attaching to transcription factors from the TEAD family, YAP stimulates the expression of genes.
YAP has a complicated role in human cancer that may vary depending on the cell type. For instance, by inducing apoptosis in response to DNA damage, YAP may act as a tumor suppressor in some cell types, such as hematological cancers.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V88146 | TEAD-IN-14 | TEAD-IN-14 (75a) is an orally active TEAD inhibitor with IC50 of <100 nM and half-life of 2.3 h in mice. | |
|
V88152 | TEAD-IN-16 | TEAD-IN-16 (compound BC-011) is a potent inhibitor of TEAD with IC50 of 72.43 μM. | |
|
V145713 | TEAD-IN-19 | TEAD-IN-19 is a TEAD transcriptional inhibitor that, at a concentration of 10 μM, inhibited TEAD1, TEAD2, TEAD3, and TEAD4 by 38.5%, 36.2%, 57.8%, and 71.3%, respectively. | |
|
V145714 | TEAD-IN-20 | 3007592-85-7 | TEAD-IN-20 is a TEAD inhibitor. |
|
V118301 | TEAD-IN-21 | TEAD-IN-21 is a highly effective, orally administered pan-TEAD inhibitor with an IC50 value of 3 nM. | |
|
V116908 | TEAD-IN-22 | 3034813-65-2 | TEAD-IN-22 (compound I) is a TEAD inhibitor. |
|
V113872 | TEAD-IN-23 | 3074990-47-6 | TEAD-IN-23 (compound 22) is a potent pan-TEAD inhibitor with an IC50 value of 10 nM. |
|
V112278 | TEAD-IN-24 | 3034813-75-4 | TEAD-IN-24 (Example 65) is a TEAD inhibitor. |
|
V69183 | TEAD-IN-6 | 2821763-12-4 | TEAD-IN-6 (Example 11-1) is a TEAD modulator that blocks the interaction between YAP1/TAZ and TEAD. |
|
V84549 | TEAD-IN-8 | 1008768-41-9 | |
|
V88144 | TEAD-IN-9 | TEAD-IN-9 (compound 17) is a TEAD1 inhibitor with IC50 of 0.29 μM. | |
|
V145712 | TEAD1/3/4-IN-1 | 2762619-63-4 | TEAD1/3/4-IN-1 is an orally effective TEAD1/3/4 inhibitor. |
|
V38733 | TED-347 | 2378626-29-8 | TED-347 (TED347) is a novel,covalent/irreversible,and allostericYAP-TEAD protein-protein interaction inhibitor with anticancer activity. |
|
V69174 | TRULI (Lats-IN-1) | 1424635-83-5 | TRULI (Lats-IN-1) is a potent, ATP-competitive inhibitor of Lats1 and Lats2 kinases. |
|
V69178 | TT-10 (TAZ-K) | 2230640-94-3 | TT-10 (TAZ-K) is an activator of YES-associated protein (YAP)-transcription enhancer domain (TEAD) activity. |
|
V146628 | Tubulin polymerization-IN-79 | Tubulin polymerization-IN-79 is a microtubule polymerization inhibitor. | |
|
V119138 | USP10-IN-4 | USP10-IN-4 is a potent ubiquitin-specific protease 10 (USP10) inhibitor with an IC50 of 10.87 μM and a Kd of 365 nM. | |
|
V146949 | Verteporfin liposome | Verteporfin liposome is the liposome-encapsulated form of verteporfin. | |
|
V111093 | VS3 | 2576427-49-9 | VS3 is a YAP-TEAD interaction inhibitor. |
|
V76351 | VT02956 | 2999763-09-4 | VT02956 is a LATS inhibitor (IC50= 0.76 nM for LATS1 and 0.52 nM for LATS2). |